Metabolic Alterations in Acute Cerebral Ischemia

Cerebral ischemia is a major health problem worldwide, that affects millions of people, leaving a major percentage of them with major disabilities, therefore becoming one of the most resource consuming pathology. Beside the blockage of blood supply of the brain that leads to loss of cellular function and neuronal necrosis, metabolic processes are modified in the whole body through mechanisms that are not fully explained yet. The results in the analysis of the 2 groups, one with 70 patients with stroke and another with 68 patients with no cerebral infarction, revealed that brain ischemia is more often found in patients with atrial fibrillation and higher blood pressure values. The metabolic changes, found in the stroke group, are represented by increased values of blood glucose, serum urea and lower levels of creatinine levels. Also, the value of leucocytes count and the erythrocyte sedimentation rate were shown to be increased in stroke patients, indicating that inflammation is highly present in cerebral infarction. In the regard of these findings, cerebral ischemia is associated with major systemic disruptions that could be significant pathogenic factors and also effects of the complex processes that take place in the affected brain region, but further investigation should be done in order to explain all the mechanisms involved and also the possible impact in prophylaxis and acute management of stroke.

[1]  A. Tuttolomondo,et al.  Neuroinflammatory Mechanisms in Ischemic Stroke: Focus on Cardioembolic Stroke, Background, and Therapeutic Approaches , 2020, International journal of molecular sciences.

[2]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association , 2020, Circulation.

[3]  M. Aminoff,et al.  Approach to the patient with neurologic disease , 2019 .

[4]  P. Whelton,et al.  Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis , 2017, JAMA cardiology.

[5]  Jun Zhu,et al.  Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study , 2016, The Lancet.

[6]  Alan D. Lopez,et al.  New strategy to reduce the global burden of stroke. , 2015, Stroke.

[7]  S. Suissa,et al.  Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes. , 2014, European heart journal.

[8]  Yong-Ku Kim,et al.  The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[9]  A. Go,et al.  Detection of Paroxysmal Atrial Fibrillation by 30-Day Event Monitoring in Cryptogenic Ischemic Stroke: The Stroke and Monitoring for PAF in Real Time (SMART) Registry , 2012, Stroke.

[10]  K. Nave,et al.  Neuroinflammation by Cytotoxic T-Lymphocytes Impairs Retrograde Axonal Transport in an Oligodendrocyte Mutant Mouse , 2012, PloS one.

[11]  S. Yusuf,et al.  Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study , 2010, The Lancet.

[12]  R. D'Agostino,et al.  Prevalence and Correlates of Silent Cerebral Infarcts in the Framingham Offspring Study , 2008, Stroke.

[13]  D. Granger,et al.  Cell adhesion molecules and ischemic stroke , 2008, Neurological research.

[14]  A. Singleton,et al.  Whole Genome Analyses Suggest Ischemic Stroke and Heart Disease Share an Association With Polymorphisms on Chromosome 9p21 , 2008, Stroke.

[15]  A. Folsom,et al.  Risk Factors for Ischemic Stroke Subtypes: The Atherosclerosis Risk in Communities Study , 2006, Stroke.

[16]  J. Kriz Inflammation in ischemic brain injury: timing is important. , 2006, Critical reviews in neurobiology.

[17]  B. Psaty,et al.  Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups , 2004, Neurology.

[18]  C. Wolfe,et al.  Cause of Stroke Recurrence Is Multifactorial: Patterns, Risk Factors, and Outcomes of Stroke Recurrence in the South London Stroke Register , 2003, Stroke.

[19]  G. Hankey Long-Term Outcome after Ischaemic Stroke/Transient Ischaemic Attack , 2003, Cerebrovascular Diseases.

[20]  Sudha Seshadri,et al.  Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. , 2002, JAMA.

[21]  F. Barone,et al.  Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  Martin A. Samuels,et al.  ADAMS AND VICTOR'S PRINCIPLES OF NEUROLOGY , 2010, Neurology.

[23]  G. Murray,et al.  Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study , 1997, BMJ.